Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wetzel

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Human Molecular Genetics|April 19, 2018
BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypesAndrea Milenkovic, Vladimir M Milenkovic, Christian H Wetzel, et al.
British Journal of Pharmacology|August 5, 1999
Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA-activated Cl- currents in cultured rat hypothalamic neuronsC H Wetzel, H Vedder, F Holsboer, et al.
Psychopharmacology|May 1, 1995
Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parametersH Wetzel, A Szegedi, C Hain, et al.
Psychopharmacology|February 1, 1995
The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patientsG Gründer, H Wetzel, A Hillert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 1, 1996
Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretionK Mann, H Bauer, C Hiemke, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trialI Anghelescu, A Szegedi, S Schlegel, et al.
Journal of Chromatography|April 19, 1991
Determination of benperidol and its reduced metabolite in human plasma by high-performance liquid chromatography and electrochemical detectionS Süss, W Seiler, C Hiemke, et al.
Psychoneuroendocrinology|March 22, 2000
Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteersR Schlösser, H Wetzel, H Dörr, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 16, 2000
Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivityA Szegedi, B Lörch, A Scheurich, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patientsW Seiler, H Wetzel, A Hillert, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Human Molecular Genetics|April 19, 2018
BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypesAndrea Milenkovic, Vladimir M Milenkovic, Christian H Wetzel, et al.
British Journal of Pharmacology|August 5, 1999
Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA-activated Cl- currents in cultured rat hypothalamic neuronsC H Wetzel, H Vedder, F Holsboer, et al.
Psychopharmacology|May 1, 1995
Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parametersH Wetzel, A Szegedi, C Hain, et al.
Psychopharmacology|February 1, 1995
The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patientsG Gründer, H Wetzel, A Hillert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 1, 1996
Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretionK Mann, H Bauer, C Hiemke, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trialI Anghelescu, A Szegedi, S Schlegel, et al.
Journal of Chromatography|April 19, 1991
Determination of benperidol and its reduced metabolite in human plasma by high-performance liquid chromatography and electrochemical detectionS Süss, W Seiler, C Hiemke, et al.
Psychoneuroendocrinology|March 22, 2000
Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteersR Schlösser, H Wetzel, H Dörr, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 16, 2000
Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivityA Szegedi, B Lörch, A Scheurich, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patientsW Seiler, H Wetzel, A Hillert, et al.
Pageof 22